Kyverna Therapeutics (KYTX) Change in Accured Expenses (2023 - 2026)
Kyverna Therapeutics' Change in Accured Expenses came in at $2.37 million for Q2 2026, up 25.1% from $1.89 million a year earlier.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kyverna Therapeutics reported Change in Accured Expenses of $510,000, down 77.3% year-over-year; for FY2025, it came in at $5.11 million, up 146.6% from FY2024.
- Going back by year, Change in Accured Expenses was $2.07 million in FY2024 (+47.8%) and $1.4 million in FY2023.
- The five-year range for quarterly Change in Accured Expenses is -$6.88 million (Q1 2026) to $3.03 million (Q4 2025).
- Year-over-year, Change in Accured Expenses increased in five of the last six quarters, with growth averaging 124.9%.
- Business Quant data shows KYTX's Change in Accured Expenses at -$6.88 million (Q1 2026), $3.03 million (Q4 2025) and $1.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kyverna Therapeutics | 382.97 Mn | 382.97 Mn | - | 2.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.37 Mn |
| Mar 31, 2026 | -6.88 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | -1.80 Mn |
| Dec 31, 2024 | 443,000.00 |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | -1.45 Mn |
| Dec 31, 2023 | 957,000.00 |
| Sep 30, 2023 | 719,000.00 |
| Jun 30, 2023 | 502,000.00 |
| Mar 31, 2023 | -777,000.00 |
API Access
Kyverna Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();